This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
One of Novo Nordisk’s next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their weight in 36 weeks, according to early-stage…
Reuters Health Information